Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens (Q39560529)
Jump to navigation
Jump to search
scientific article published on 11 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens |
scientific article published on 11 April 2011 |
Statements
1 reference
Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens (English)
1 reference
David Miller
1 reference
Victor M Rivera
1 reference
Rachel M Squillace
1 reference
Lori Berk
1 reference
Scott D Wardwell
1 reference
Yaoyu Ning
1 reference
Roy Pollock
1 reference
Narayana I Narasimhan
1 reference
John D Iuliucci
1 reference
Frank Wang
1 reference
Tim Clackson
1 reference
11 April 2011
1 reference
1 reference
Identifiers
1 reference